email print share on Facebook share on Twitter share on LinkedIn share on reddit pin on Pinterest

DISTRIBUTION UK

Artificial Eye, Sky travel on Route Irish

by 

Artificial Eye Film Company and Sky Movies Box Office will release Ken Loach’s new film Route Irish [+see also:
film review
trailer
film profile
]
on March 18. The film will get a 20-cinema release across the UK while simultaneously being made available to Sky’s 10 million subscribers for two weeks from that day.

Additionally, in keeping with the film’s multiplatform release strategy, Route Irish will also be available day and date on Curzon Cinemas’ new on demand service Curzon On Demand and FilmFlex, which is available to Virgin subscribers.

(The article continues below - Commercial information)

Artificial Eye CEO Philip Knatchbull said, “This is the fourth film we have co-released with BSkyB where ‘Public’ and ‘Home’ Cinema become synonymous. The inclusion this time of both Curzon On demand and FilmFlex give added impetus in establishing this new release pattern for future films.”

Artificial Eye and Sky’s previous simultaneous releases were Fatih Akin’s The Edge of Heaven [+see also:
film review
trailer
interview: Fatih Akin
interview: Klaus Maeck
film profile
]
, Erik Zonca’s Julia [+see also:
trailer
film profile
]
and Todd Solondz’s Life During Wartime.

Route Irish is a conspiracy thriller where Loach and screenwriter Paul Laverty (Looking for Eric [+see also:
film review
trailer
interview: Cannes 2009
Ken Loach

interview: Steve Evets - actor
film profile
]
) examine the effects of combat on security contractors – the new “soldiers” of modern warfare - who witness the horrors of combat and are subject to post-combat stress yet receive little support from the state upon return home. The film is produced by Rebecca O’Brien with Executive Producers Pascal Caucheteux and Vincent Maraval.

Route Irish is the unofficial name for the deadly and now infamous stretch of road between Baghdad airport and the Green Zone.

(The article continues below - Commercial information)

Did you enjoy reading this article? Please subscribe to our newsletter to receive more stories like this directly in your inbox.

Privacy Policy